164O Health-related quality of life (HRQoL) with pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as 1L treatment for advanced triple-negative breast cancer (TNBC): Results from KEYNOTE-355
| Autor: | D.W. Cescon, P. Schmid, H.S. Rugo, S-A. Im, M. Md Yusof, C.E. Gallardo, O. Lipatov, C.H. Barrios, J.M. Perez Garcia, H. Iwata, N. Masuda, M.A. Torregroza Otero, E. Gokmen, S. Loi, A. Haiderali, X. Zhou, Z. Guo, A. Martin Nguyen, J. Cortés |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S197-S198 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.03.183 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|